Drug profile · INN
denosumab-dssb
DENOSUMAB-DSSB
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
denosumab-dssb (DENOSUMAB-DSSB) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN denosumab-dssb
Brand DENOSUMAB-DSSB
Route SUBCUTANEOUS
Formulation INJECTABLE
Frequently asked questions
What is denosumab-dssb?
denosumab-dssb (DENOSUMAB-DSSB) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for denosumab-dssb?
DENOSUMAB-DSSB is a marketed brand name for denosumab-dssb. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of denosumab-dssb?
denosumab-dssb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.